Live at ViVE S2 E25: Innovation at the Intersection of Pharma and Digital Health with John Kraus
There are two critical topics at the intersection of the pharmaceutical industry and digital health.
The first is how pharmaceutical companies can effectively integrate digital technology to improve treatment plans.
The second is addressing the challenges clinical trials face regarding diversity, consent, and stigma.
Both topics are essential in improving patient outcomes and advancing medical research.
Dr. John Kraus is Otsuka's Executive Vice President and Chief Medical Officer. With over 25 years of experience in clinical, academic, pharmaceutical medicine, and drug development, John's patient-centered approach and dedication to advancing care for underserved patients drive his work at Otsuka.
On this episode of “Live at ViVE,” Dr. Kraus joins hosts Dr. Gautam Gulati and Dr. Jessica Shepherd to explore the importance of integrating digital technology into pharmaceutical drug development and how it can improve patient outcomes. They also discuss the challenges of diversity, consent, and stigma in clinical trials and how Otsuka is working to address them.
Dr. Kraus also delves into the challenges faced in clinical trials, particularly in the psychiatric and neurologic space, and the need for improvement in the inclusivity, consent, and monitoring of outcomes.
Listen in to learn about the future of pharmaceutical companies and their integration with digital health, and the importance of patient-centered approaches in advancing care.
Topics Covered
- Dr. Kraus shares Otsuka's approach to drug development and creating products for better health worldwide
- The intersection of digital health and the pharmaceutical industry
- The importance of creating holistic solutions that put patients at the center
- The potential of digital therapeutics in treating mental health disorders
- The challenges of conducting clinical trials in the mental health space
- The responsibility of pharmaceutical companies to address historical exploitation in clinical trials
- The need for diverse researcher and investigator pools to better engage with patients
- The importance of outreach and education in clinical trial recruitment
- Dr. Kraus shares Otsuka's focus on collaboration with other organizations to drive innovation
Connect with Dr. John Kraus
John on LinkedIn
Connect with Dr. Gautam Gulati & Dr. Jessica Shepherd
Dr. Gulati on Twitter
Dr. Gulati on LinkedIn
Dr. Shepherd on LinkedIn
Dr. Shepherd on Twitter
Resources